Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2018, Article ID 1615092, 6 pages
https://doi.org/10.1155/2018/1615092
Clinical Study

Effects of Vonoprazan Compared with Esomeprazole on the Healing of Artificial Postendoscopic Submucosal Dissection Ulcers: A Prospective, Multicenter, Two-Arm, Randomized Controlled Trial

1Department of Gastroenterology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan
2Division of Endoscopy, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Japan
3Advanced Medical Research Center, Yokohama City University, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan

Correspondence should be addressed to Shin Maeda; pj.ca.uc-amahokoy@adeams

Received 3 October 2017; Accepted 6 December 2017; Published 18 February 2018

Academic Editor: Tatsuya Toyokawa

Copyright © 2018 Yasuaki Ishii et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Akasaka, T. Nishida, S. Tsutsui et al., “Short-term outcomes of endoscopic submucosal dissection (ESD) for early gastric neoplasm: multicenter survey by Osaka University ESD study group,” Digestive Endoscopy, vol. 23, no. 1, pp. 73–77, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Toyokawa, T. Inaba, S. Omote et al., “Risk factors for perforation and delayed bleeding associated with endoscopic submucosal dissection for early gastric neoplasms: analysis of 1123 lesions,” Journal of Gastroenterology and Hepatology, vol. 27, no. 5, pp. 907–912, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Kato, H. Araki, F. Onogi et al., “Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection—a randomized controlled study,” Journal of Gastroenterology, vol. 45, no. 3, pp. 285–290, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Fujiwara, Y. Morita, T. Toyonaga et al., “A randomized controlled trial of rebamipide plus rabeprazole for the healing of artificial ulcers after endoscopic submucosal dissection,” Journal of Gastroenterology, vol. 46, no. 5, pp. 595–602, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Kobayashi, M. Takeuchi, S. Hashimoto et al., “Contributing factors to gastric ulcer healing after endoscopic submucosal dissection including the promoting effect of rebamipide,” Digestive Diseases and Sciences, vol. 57, no. 1, pp. 119–126, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Hori, A. Imanishi, J. Matsukawa et al., “1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438), a novel and potent potassium-competitive acid blocker for the treatment of acid-related diseases,” The Journal of Pharmacology and Experimental Therapeutics, vol. 335, no. 1, pp. 231–238, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Otake, Y. Sakurai, H. Nishida et al., “Characteristics of the novel potassium-competitive acid blocker vonoprazan fumarate (TAK-438),” Advances in Therapy, vol. 33, no. 7, pp. 1140–1157, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Kagawa, M. Iwamuro, S. Ishikawa et al., “Vonoprazan prevents bleeding from endoscopic submucosal dissection-induced gastric ulcers,” Alimentary Pharmacology and Therapeutics, vol. 44, no. 6, pp. 583–591, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Takahashi, Y. Sato, J. Kohisa et al., “Vonoprazan 20 mg vs lansoprazole 30 mg for endoscopic submucosal dissection-induced gastric ulcers,” World Journal of Gastrointestinal Endoscopy, vol. 8, no. 19, pp. 716–722, 2016. View at Publisher · View at Google Scholar
  10. D. Maruoka, M. Arai, S. Kasamatsu et al., “Vonoprazan is superior to proton pump inhibitors in healing artificial ulcers of the stomach post-endoscopic submucosal dissection: a propensity score-matching analysis,” Digestive Endoscopy, vol. 29, no. 1, pp. 57–64, 2017. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Tsuchiya, Y. Kato, E. Tanida et al., “Effect of vonoprazan on the treatment of artificial gastric ulcers after endoscopic submucosal dissection: prospective randomized controlled trial,” Digestive Endoscopy, vol. 29, no. 5, pp. 576–583, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. S.-Y. Lee, J. J. Kim, J. H. Lee et al., “Healing rate of EMR-induced ulcer in relation to the duration of treatment with omeprazole,” Gastrointestinal Endoscopy, vol. 60, no. 2, pp. 213–217, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Kanda, “Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics,” Bone Marrow Transplantation, vol. 48, no. 3, pp. 452–458, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Niimi, M. Fujishiro, O. Goto et al., “Prospective single-arm trial of two-week rabeprazole treatment for ulcer healing after gastric endoscopic submucosal dissection,” Digestive Endoscopy, vol. 24, no. 2, pp. 110–116, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. J. H. Cheon, J. H. Kim, S. K. Lee, T. I. Kim, W. H. Kim, and Y. C. Lee, “Helicobacter pylori eradication therapy may facilitate gastric ulcer healing after endoscopic mucosal resection: a prospective randomized study,” Helicobacter, vol. 13, no. 6, pp. 564–571, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Isomoto, S. Shikuwa, N. Yamaguchi et al., “Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study,” Gut, vol. 58, no. 3, pp. 331–336, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Dong, K. Wei, J. Deng et al., “Effects of antithrombotic therapy on bleeding after endoscopic submucosal dissection,” Gastrointestinal Endoscopy, vol. 86, no. 5, pp. 807–816, 2017. View at Publisher · View at Google Scholar
  18. J. Wang, X. Guo, C. Ye et al., “Efficacy and safety of proton pump inhibitors (PPIs) plus rebamipide for endoscopic submucosal dissection-induced ulcers: a meta-analysis,” Internal Medicine, vol. 53, no. 12, pp. 1243–1248, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Yamasaki, N. Kawaguchi, M. Nonaka et al., “In vitro metabolism of TAK-438, vonoprazan fumarate, a novel potassium-competitive acid blocker,” Xenobiotica, vol. 47, no. 12, pp. 1027–1034, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Kagami, S. Sahara, H. Ichikawa et al., “Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotype,” Alimentary Pharmacology and Therapeutics, vol. 43, no. 10, pp. 1048–1059, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Lindberg, D. Keeling, J. Fryklund, T. Andersson, P. Lundborg, and E. Carlsson, “Esomeprazole — enhanced bio-availability, specificity for the proton pump and inhibition of acid secretion,” Alimentary Pharmacology and Therapeutics, vol. 17, no. 4, pp. 481–488, 2003. View at Publisher · View at Google Scholar · View at Scopus